104 related articles for article (PubMed ID: 1001240)
1. [Cerebral metabolism of dopamine and of serotonin during Alzheimer and Pick's diseases. Dynamic study by the test using probenecid].
Guard O; Renaud B; Chazot G
Encephale; 1976; 2(4):293-303. PubMed ID: 1001240
[TBL] [Abstract][Full Text] [Related]
2. [Central metabolism of dopamine and serotonin. I. Determination of cerebrospinal fluid levels of HVA and 5-HIAA by the probenecid test (modified)].
Carrieri P; Campanella G; Mandarini A; Orefice G; Buscaino GA
Acta Neurol (Napoli); 1976; 31(5):558-64. PubMed ID: 1015382
[No Abstract] [Full Text] [Related]
3. Clinical application of the probenecid test for measurement of monoamine turnover in the CNS.
Faull KF; Kraemer HC; Barchas JD; Berger PA
Biol Psychiatry; 1981 Sep; 16(9):879-99. PubMed ID: 6170352
[TBL] [Abstract][Full Text] [Related]
4. [Central metabolism of dopamine and serotonin. III. Preliminary findings on the relations between dopamine metabolism and purine metabolism in the nervous system].
Campanella G; Orefice G; Carrieri P; Mandarini A; Buscaino GA
Acta Neurol (Napoli); 1976; 31(5):571-9. PubMed ID: 138341
[No Abstract] [Full Text] [Related]
5. [Use of the probenecid test for the diagnosis and treatment of Parkinsonism. Review of the literature and personal experience (author's transl)].
Vanderheyden JE; Dekoninck WJ; Lefèvre A; Mendlewicz J
Encephale; 1980; 6(4):349-66. PubMed ID: 6160034
[TBL] [Abstract][Full Text] [Related]
6. Apomorphine, pimozide, L-Dopa and the probenecid test in Huntington's chorea.
Lal S; De la Vega C; Garelis E; Sourkes TL
Psychiatr Neurol Neurochir; 1973; 76(2):113-7. PubMed ID: 4267059
[No Abstract] [Full Text] [Related]
7. [Exploration of the metabolism of brain serotonin and dopamine in prolonged traumatic coma:prognostic value].
Artru F; Gagnieu MC; Jourdan C; Quincy C; Renaud B; Deleuze R
Agressologie; 1986 Nov; 27(11):923-5. PubMed ID: 2435184
[No Abstract] [Full Text] [Related]
8. [Disorders of glucose metabolism in Pick's disease].
Szelies B; Karenberg A
Fortschr Neurol Psychiatr; 1986 Dec; 54(12):393-7. PubMed ID: 3493192
[TBL] [Abstract][Full Text] [Related]
9. [Central metabolism of dopamine and serotonin. IV. Preliminary determinations of cerebrospinal fluid HVA and 5-HIAA in epileptic syndromes].
Mandarini A; Buscaino GA; Rossi V; Orefice G; Carrieri P; Campanella G
Acta Neurol (Napoli); 1976; 31(5):628-31. PubMed ID: 1015386
[No Abstract] [Full Text] [Related]
10. 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.
Stuerenburg HJ; Ganzer S; Müller-Thomsen T
Neuro Endocrinol Lett; 2004 Dec; 25(6):435-7. PubMed ID: 15665806
[TBL] [Abstract][Full Text] [Related]
11. Serotoninergic dysfunction in the 47, XYY syndrome.
Bioulac B; Benezech M; Renaud B; Noel B; Roche D
Biol Psychiatry; 1980 Dec; 15(6):917-23. PubMed ID: 6161648
[TBL] [Abstract][Full Text] [Related]
12. Laboratory examinations correlated with severity of dementia.
Oishi M; Mochizuki Y; Yoshihashi H; Takasu T; Nakano E
Ann Clin Lab Sci; 1996; 26(4):340-5. PubMed ID: 8800434
[TBL] [Abstract][Full Text] [Related]
13. The probenecid test in Parkinson's disease.
Lakke JP; Korf J; Hoorntje S; Schut T; van Praag HM
Psychiatr Neurol Neurochir; 1973; 76(2):139-46. PubMed ID: 4700931
[No Abstract] [Full Text] [Related]
14. Monoamine metabolism and depression in Parkinson patients.
Puite JK; Schut T; van Praag HM; Lakke JP
Psychiatr Neurol Neurochir; 1973; 76(1):61-70. PubMed ID: 4699106
[No Abstract] [Full Text] [Related]
15. Dopaminergic agonist effects on Parkinsonian clinical features and brain monamine metabolism.
Rinne UK; Sonninen V; Marttila R
Adv Neurol; 1975; 9():383-92. PubMed ID: 1096575
[TBL] [Abstract][Full Text] [Related]
16. Chromatin structure in dementia.
McLachlan DR; Lewis PN; Lukiw WJ; Sima A; Bergeron C; De Boni U
Ann Neurol; 1984 Apr; 15(4):329-34. PubMed ID: 6742779
[TBL] [Abstract][Full Text] [Related]
17. Neurotransmitters in dementia.
Nakamura S; Koshimura K; Kato T; Yamao S; Iijima S; Nagata H; Miyata S; Fujiyoshi K; Okamoto K; Suga H
Clin Ther; 1984; 7 Spec No():18-34. PubMed ID: 6152197
[TBL] [Abstract][Full Text] [Related]
18. [Disturbances of monoamine metabolism in organic presenile and senile dementia].
Gottfries CG
Lakartidningen; 1974 Mar; 71(13):1284-5. PubMed ID: 4823610
[No Abstract] [Full Text] [Related]
19. [Value of the probenecid test in the diagnosis and treatment of parkinson disease].
Vanderheyden JE; Noel G; Mendlewicz J
Acta Neurol Belg; 1982; 82(6):339-52. PubMed ID: 7164768
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease: monoamines and spiperone binding reduced in nucleus basalis.
Sparks DL; Markesbery WR; Slevin JT
Ann Neurol; 1986 Jun; 19(6):602-4. PubMed ID: 2425718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
